Renaissance Technologies
LUMO

Renaissance Technologies’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Renaissance Technologies’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-213,814
Closed -$827K – 3998
2024
Q3 		$827K Sell
213,814
-2,000
-0.9% -$5.54K ﹤0.01% 2558
2024
Q2 		$501K Sell
215,814
-2,200
-1% -$5.68K ﹤0.01% 2689
2024
Q1 		$615K Sell
218,014
-3,600
-2% -$10.7K ﹤0.01% 2779
2023
Q4 		$705K Sell
221,614
-5,100
-2% -$17.4K ﹤0.01% 2596
2023
Q3 		$748K Sell
226,714
-4,445
-2% -$13.9K ﹤0.01% 2490
2023
Q2 		$763K Buy
231,159
+1,245
+0.5% +$4.39K ﹤0.01% 2639
2023
Q1 		$761K Sell
229,914
-3,200
-1% -$11.2K ﹤0.01% 2646
2022
Q4 		$842K Sell
233,114
-17,399
-7% -$114K ﹤0.01% 2632
2022
Q3 		$2.22M Sell
250,513
-19,599
-7% -$163K ﹤0.01% 1948
2022
Q2 		$2.08M Sell
270,112
-1,600
-0.6% -$12.8K ﹤0.01% 2157
2022
Q1 		$2.55M Sell
271,712
-5,400
-2% -$48.2K ﹤0.01% 2040
2021
Q4 		$1.92M Sell
277,112
-9,300
-3% -$78.1K ﹤0.01% 2181
2021
Q3 		$2.72M Sell
286,412
-19,345
-6% -$182K ﹤0.01% 1864
2021
Q2 		$3.06M Sell
305,757
-26,662
-8% -$297K ﹤0.01% 1954
2021
Q1 		$3.89M Buy
332,419
+23,607
+8% +$397K ﹤0.01% 1807
2020
Q4 		$11M Buy
308,812
+2,700
+0.9% +$46.6K 0.01% 1097
2020
Q3 		$4.23M Sell
306,112
-3,079
-1% -$46K ﹤0.01% 1668
2020
Q2 		$5.1M Sell
309,191
-3,900
-1% -$46.4K ﹤0.01% 1645
2020
Q1 		$2.66M Sell
313,091
-13,358
-4% -$187K ﹤0.01% 1904
2019
Q4 		$7.43M Sell
326,449
-440
-0.1% -$6.28K 0.01% 1627
2019
Q3 		$4.68M Buy
326,889
+1,615
+0.5% +$23.7K ﹤0.01% 1837
2019
Q2 		$4.33M Buy
325,274
+22,850
+8% +$345K ﹤0.01% 1890
2019
Q1 		$5.25M Buy
302,424
+73,423
+32% +$1.09M ﹤0.01% 1772
2018
Q4 		$3.13M Buy
229,001
+80,559
+54% +$1.42M ﹤0.01% 2006
2018
Q3 		$3.19M Buy
148,442
+103,431
+230% +$3.15M ﹤0.01% 2048
2018
Q2 		$1.93M Buy
45,011
+25,074
+126% +$1.15M ﹤0.01% 2276
2018
Q1 		$1.3M Buy
+19,937
New +$1.41M ﹤0.01% 2537
2017
Q3 		– Sell
-23,878
Closed -$1.58M – 3411
2017
Q2 		$1.58M Buy
23,878
+18,556
+349% +$2.3M ﹤0.01% 2384
2017
Q1 		$1.15M Sell
5,322
-10,878
-67% -$1.55M ﹤0.01% 2485
2016
Q4 		$1.5M Sell
16,200
-22,333
-58% -$2.52M ﹤0.01% 2362
2016
Q3 		$5.21M Sell
38,533
-52,078
-57% -$5.17M 0.01% 1575
2016
Q2 		$9.18M Buy
90,611
+9,867
+12% +$1.22M 0.02% 1203
2016
Q1 		$13.2M Buy
80,744
+74,419
+1,177% +$15.1M 0.03% 939
2015
Q4 		$2.07M Sell
6,325
-11,239
-64% -$3.66M ﹤0.01% 2088
2015
Q3 		$5.67M Buy
+17,564
New +$7.72M 0.01% 1300
2014
Q1 		– Sell
-3,133
Closed -$621K – 3051
2013
Q4 		$621K Buy
+3,133
New +$557K ﹤0.01% 2281

Renaissance Technologies's LUMO Position: Q4 2024 in Review

Renaissance Technologies sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 213,814 shares — an estimated $827K sold.

Renaissance Technologies first reported a position in LUMO in Q4 2013 and held it in 36 quarters. The position peaked at $13.2M in Q1 2016. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Renaissance Technologies reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 213,814 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $827K.
  • Renaissance Technologies first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 36 quarters.
  • Renaissance Technologies's Lumos Pharma, Inc. Common Stock position peaked at $13.2M in Q1 2016.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.